Abiomed to Showcase Impella(R) Heart Recovery Platform at American College of Cardiology Annual 2009 Meeting

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of heart recovery products designed to recover hearts and eliminate in-hospital deaths from heart attacks and high risk percutaneous coronary interventions (PCI), today announced its schedule of events at the American College of Cardiology (ACC) 58th Annual 2009 Scientific Session, being held March 29 - 31, at the Orlando Convention Center in Orlando, Florida. The ACC conference features the latest and most innovative findings in cardiovascular science, as well as the most clinically relevant practical applications. Abiomed will exhibit its comprehensive portfolio of heart recovery products spanning the continuum of cardiovascular patient care from the catheterization lab (cath lab) to the surgery suite.

MORE ON THIS TOPIC